PUCCI, Ida
 Distribuzione geografica
Continente #
NA - Nord America 6.316
EU - Europa 4.498
AS - Asia 3.545
SA - Sud America 465
AF - Africa 139
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 14.969
Nazione #
US - Stati Uniti d'America 6.210
SG - Singapore 1.210
RU - Federazione Russa 956
CN - Cina 930
FI - Finlandia 789
UA - Ucraina 625
IT - Italia 557
DE - Germania 425
BR - Brasile 383
HK - Hong Kong 368
VN - Vietnam 352
PL - Polonia 247
IE - Irlanda 235
GB - Regno Unito 196
FR - Francia 168
JP - Giappone 153
SE - Svezia 119
KR - Corea 103
IN - India 89
BD - Bangladesh 65
IQ - Iraq 45
CI - Costa d'Avorio 44
RO - Romania 43
CA - Canada 39
MX - Messico 38
BE - Belgio 37
NL - Olanda 35
TR - Turchia 33
PK - Pakistan 30
AR - Argentina 29
UZ - Uzbekistan 28
ZA - Sudafrica 28
KE - Kenya 17
ID - Indonesia 16
IR - Iran 15
ES - Italia 14
VE - Venezuela 12
EG - Egitto 11
JO - Giordania 11
NP - Nepal 11
AT - Austria 10
CH - Svizzera 10
CL - Cile 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
CO - Colombia 9
ET - Etiopia 9
MY - Malesia 9
EC - Ecuador 8
BH - Bahrain 7
JM - Giamaica 7
PH - Filippine 7
SA - Arabia Saudita 7
AZ - Azerbaigian 6
GR - Grecia 6
KZ - Kazakistan 6
LT - Lituania 6
PY - Paraguay 6
TW - Taiwan 6
CZ - Repubblica Ceca 5
LB - Libano 5
NG - Nigeria 5
TN - Tunisia 5
BB - Barbados 4
CR - Costa Rica 4
GE - Georgia 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LK - Sri Lanka 3
MD - Moldavia 3
NI - Nicaragua 3
EE - Estonia 2
GA - Gabon 2
GT - Guatemala 2
HU - Ungheria 2
KW - Kuwait 2
PA - Panama 2
PE - Perù 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
GY - Guiana 1
HN - Honduras 1
HT - Haiti 1
KH - Cambogia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
Totale 14.967
Città #
Ashburn 807
Singapore 784
San Jose 377
Ann Arbor 365
Hong Kong 354
Jacksonville 353
Woodbridge 324
Chandler 282
Fairfield 275
Wilmington 235
Dublin 232
Zgierz 212
Houston 199
Medford 175
Beijing 167
Moscow 157
Dallas 149
Tokyo 148
Des Moines 144
Frankfurt am Main 136
Nanjing 131
Santa Clara 129
Ho Chi Minh City 116
Princeton 109
Seattle 98
Los Angeles 94
Tulsa 92
Lauterbourg 87
Cambridge 85
The Dalles 79
Hanoi 77
Hefei 76
Boardman 73
New York 71
Dearborn 65
Palermo 65
Buffalo 64
Helsinki 60
Nanchang 46
Abidjan 44
São Paulo 44
Venice 41
Brussels 37
Milan 34
Chicago 33
Council Bluffs 33
Hebei 33
Shenyang 32
Tianjin 32
Ludwigshafen am Rhein 30
Seongnam 27
Changsha 26
Jinan 26
Da Nang 23
Jiaxing 23
Munich 23
Warsaw 23
San Diego 22
London 21
Tashkent 21
Verona 21
Amsterdam 19
Columbus 18
Denver 18
Haiphong 18
Seoul 18
Baghdad 17
City of London 17
Altamura 16
Johannesburg 16
Orem 16
Redondo Beach 16
Saint Petersburg 16
Nairobi 15
Rome 15
Cardiff 14
Chennai 14
Zhengzhou 14
Atlanta 13
Mexico City 13
Turku 13
Lawrence 12
Orange 12
Auburn Hills 11
Hangzhou 11
Kumar 11
Montreal 11
Ningbo 11
Phoenix 11
Berlin 10
Biên Hòa 10
Düsseldorf 10
Toronto 10
Addis Ababa 9
Amman 9
Brooklyn 9
Kitzingen 9
Norwalk 9
Tehran 9
Bremen 8
Totale 8.649
Nome #
Effetti indotti da fattori diffusibili fibroblastici sull'espressione proteica di cellule di carcinoma mammario. 383
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 288
Multiple changes induced by fibroblasts on breast cancer cells. 265
Anti-oncogenic role of decorin: identification of new markers. 229
Large-scale proteomic identification of S100 proteins in breast cancer tissues. 223
Retrospective Proteomic Screening of 100 Breast Cancer Tissues 214
Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines. 209
COMPARATIVE PROTEOMIC PROFILING OF NORMAL AND BREAST CANCER CELLS UNDER HYPOXIC CONDITIONS 205
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION 201
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment 198
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera 197
Decorin Transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC 195
Breast cancer proteomics: from research to clinical applications. 194
Cytoskeleton and Proteomic Changes Induced by Fibroblasts on Breast Cancer Cells 186
Effects of endothelial cells on breast cancer cells in a co-culture system. 186
Proteo-genomic modulations induced on breast cancer cells by endothelial cells 183
Proteomic Analysis of Protein Components in Periodontal Ligament Fibroblasts 180
Comparative Proteomic and immunohistochemistry analyses to study alphaenolase/MBP-1 isoforms expression in breast cancer 178
Fibroblast’s role in breast cancer: a proteomic approach 175
Comparative proteomics of breast cancer surgical tissues 174
S-100 calcium binding proteins as potential markers for breast cancer metastasis. 170
Differential protein expression in cytokine-sensitive and -resistant pancreatic beta cell lines 167
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer 166
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy 163
Differential proteomics of thyroid carcinoma cell lines 161
Genomic and proteomic profiling of decorin transfected breast cancer cells. 160
Analysis of Trastuzumab effects in breast cancer cells in vitro 160
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 158
Fibroblasts enhance proliferation and invasion of Breast Cancer Cells (8701-BC) 158
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer 158
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 157
Two-Dimensional Electrophoresis Analysis of Proteins Extracted From Leaves of Homozygous and Heterozygous Citrus 157
Proteomic profling of B-cell chronic lymphocytic leukemia 153
Correlation between MMPS and proteomic profiles of breast cancer tissues 151
DIFFERENTIAL PROTEOMIC ANALYSIS OF THYROID CARCINOMA CELL LlNES 151
New insight on genomic and proteomic profiling of decorin-transfected breast cancer cells. 150
Ectopic decorin induces proteomic and phenotypic modulation of breast cancer cells. 147
Ectopic decorin induces proteomic and phenotypic modulation of breast cells. 147
Proteomic analysis of extracellular vesicles shed in vitro by MDA MB 231 breast carcinoma cells 146
Proteomic and genomic modulations of breast cancer cells co-cultured with endothelial cells. 144
Multiple effects induced by herceptin® on 8701-BC breast cancer cells 143
Gene ontology-based annotation and comparative analysis of proteins extracted from proteomics of 100 breast cancer patients. 142
Decorin transfection in breast cancer cells (8701-BC) induces proteomic modulation, cytoskeleton reorganization and inhibits matrix proteases 141
Proteomic profiling of B-cell chronic lymphocytic leukemia. A pilot study. 140
Evaluation of cellular response of breast cancer cells grown on distinctive collagen substrates 139
Matrix metalloproteases monitoring during neoadjuvant breast cancer therapy. An ongoing study. 138
Herceptin-resistance in breast cancer cells: a proteomic study. 138
Analisi di cluster proteomici per l'identificazione di sottopopolazioni di pazienti con carcinoma mammario 136
Modulazione del proteoma indotta in cellule di carcinoma mammario da decorina ectopica 135
Fibroblast’s influence on breast cancer cells. 133
Involvement of gelatinases in breast cancer: correlation with clinical parameters and 2D-IPG applications. 133
A PROTEOMIC CLUSTER FOR OSTEOTROPIC BREAST CANCER CELLS 132
Proteomic Detection of Breast-Cancer Subpopulations. 132
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico 131
Effects of fibroblast diffusible factors on proteomic modulation of breast cancer cells. 130
Proteomics and proteomic modulations of breast cancer cells 129
La post-genomica in Oncologia: prospettive e problematiche. Analisi proteomica 129
Cross-talk between breast cancer cells and fibroblasts in coculture system. 128
Cross-talk between fibroblast and breast cancer cells: a proteomic study 128
Herceptin-resistance in breast cancer cells: a proteomic approach 128
Proteomic modulation of neoplastic cells by extracellular matrix components 127
Differential proteomic and phenotypic behavior of papillary and anaplastic thyroid carcinoma cell lines: an updated study 126
Ectopic decorin induces proteomic and cytoskeleton modulation of breast cancer cells 125
Different collagen substrates induce the expression of alternative forms of keratins and vimentin in breast cancer cells. 125
PROTEOMIC MODULATION IN BREAST CANCER CELLS INDUCED BY MICROENVIRONMENT COMPONENTS 125
Effects of Hypoxia on 8701-BC cancer cells. 125
Levels of circulating gelatinases and proteomic correlations in breast cancer patients. 125
LARGE-SCALE COMPARATIVE PROTEOMICS OF BREAST CANCER SURGICAL TISSUES 125
Zymographic detection of MMP-2 and MMP-9 in breast cancer sera patients during chemotherapy. 124
Occurrence of S100A7 in a large sample-set of breast cancer tissues 124
Proteomic detection of S100 proteins in breastcancer tissues 124
Cytoskeleton modulation in breast cancer cells induced by stromal microenvironment. 123
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH 122
Studio dell'interattoma di PAR-6 in cellule di carcinoma mammario 8701-BC 122
Herceptin Resistance and Malignant Potential of Cancer Cells. 120
Large-scale comparative proteomics of breast surgical tissues 120
Identificazione di forme multiple di cheratine 8, 18 e vimentina espresse da cellule di carcinoma mammario coltivate su differenti substrati collagene 117
S100S PROTEIN EXPRESSION IN A LARGE SAMPLE-SET OF BREAST CANCER TISSUES 117
The fibroblasts: co-actors in cancer. 116
Hypoxia influence on differential gene expression of 8701-BC cancer cells. 114
EFFETTI DEL TRASTUZUMAB SUL PROTEOMA DI CELLULE DI CARCINOMA MAMMARIO OVER-ESPRIMENTI HER-2 113
Multi-omics analysis of epithelial-to mesenchymal transition mediators in breast cancer 112
PROTEOMIC EFFECTS INDUCED BY MICROENVIRONMENT COMPONENTS ON 8701-BC BREAST CANCER CELLS: AN UPDATED REPORT 112
IDENTIFICATION OF TYPE V COLLAGEN-BINDING PROTEINS IN 8701-BC BREAST CANCER CELLS 112
Proteomic modulation induced in fibroblasts by breast cancer cells (8701‐BC)paracrine factors. 110
Decorin transfection induces proteomic modulation and cytoskeletal rioganization in breast cancer cells (8701-BC) 110
Proteomic profile of hypoxic breast cancer cells 108
Zymographic detection of matrix proteases in breast cancer biopsies by mono- and two-dimensional electrophoresis 107
Proteomic profiling of Trastuzumab (Herceptin(R))-sensitive and -resistant SKBR-3 breast cancer cells. 105
Modulation of neoplastic phenotype by Extracellular Matrix components. 104
Permissive and restrictive influences from breast cancer stroma 103
Proteomic modulation of breast cancer cells (8701-BC) cocultured with normal human fibroblasts. 102
Identification of multiple forms of keratins expressed by brest cancer cells coltured on different collagen substrates. 102
LARGE-SCALE SCREENING OF MATRIX METALLOPROTEINASES IN BREAST CANCER PATIENTS AND CLINICAL-MOLECULAR CORRELATIONS 101
Fibroblast-derived factors modulate breast cancer cell proteomics. 100
Extraction of Proteins From Leaves of Homozygous and Heterozygous Citrus for Two-Dimensional Electrophoresis Analysis. 100
MMP-2, MMP-9 and MMP-14 in breast cancer: clinicopathological correlations. 99
The cytoskeletal network in fibroblasts cultured from PXE patients 97
Identification of multiple forms of keratins expressed by breast cancer cells coltured on different collagen substrates. 97
Proteomic analysis of Herceptin-resistance breast cancer cells 92
Totale 14.604
Categoria #
all - tutte 47.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 0 0 109
2021/2022896 11 233 8 11 27 26 18 50 102 157 29 224
2022/20231.030 159 67 13 92 129 196 104 59 153 13 37 8
2023/2024635 30 106 31 100 80 115 53 23 0 12 6 79
2024/20251.569 29 107 84 122 76 31 116 74 122 163 264 381
2025/20266.160 465 160 361 453 609 762 707 661 466 1.036 439 41
Totale 15.197